📌 Archived version v1.1 (2026-05-31) — a fixed snapshot for citation. View current version →

SQ-LIP-000009 · v1.1 (archived) · View current version →

Is lipedema linked to gluten sensitivity, celiac disease, or HLA-DQ2/DQ8?

ComorbiditiesGenetics
Current answer

Based on currently indexed evidence, a possible association between lipedema and celiac-related immunogenetics has been raised but remains unproven and rests entirely on low- to very-low-quality, cross-sectional and descriptive data. One convenience-sample cross-sectional study reported a modestly higher prevalence of celiac-associated HLA-DQ2/DQ8 haplotypes in women with lipedema versus a historical general-population comparator (any HLA 61.1% vs 53.7%; both haplotypes 7.4% vs 1.2%), and a new case series of five male lipedema patients found HLA-DQ2/DQ8 positivity in the single patient who was typed, citing prior prevalence figures and applying a gluten-free diet on that basis. Separately, NHANES cross-sectional analyses found lower gynoid percent fat in women with serologically confirmed celiac disease (39.5% vs 42.6%), persisting in overweight/obese strata, and a food-specific IgG study described a paradoxical pattern of slightly more positive food reactions despite markedly lower total IgG in lipedema. None of these analyses demonstrates a causal mechanism, and all carry small case numbers, high or moderate risk of bias, and reliance on historical or indirect comparators. No high-quality (RCT, meta-analytic, or large prospective) evidence currently links lipedema to gluten sensitivity, celiac disease, or HLA-DQ2/DQ8.

Knowledge stateEmerging
Knowledge freshness86% recent · current evidence base
Created2026-05-30
Last updated2026-05-31
Human reviewnot yet reviewed
4supporting
0contradicting
1refining / context

Knowledge freshness = share of the 7 indexed evidence sources from the last 5 years (newest 2026, oldest 2015) . Low freshness flags an ageing evidence base — not that the answer is wrong.

Evidence over time

19342026First literature mention: Clinical and Biologic Considerations of Obesity and Certain Allied Conditions · originTHE PREVALENCE OF HLA DQ2 AND DQ8 IN PATIENTS WITH CELIAC DISEASE, IN FAMILY AND IN GENERAL POPULATION — CECILIO & BONATTO (2015) · supportingAssessing the Prevalence of HLA-DQ2 and HLA-DQ8 in Lipedema Patients and the Potential Benefits of a Gluten-Free Diet — Amato et al. (2023) · supportingThe Lipedema Phenotype is Inversely Associated with Celiac Disease Autoimmunity: Testing the Immunological Shield Hypothesis in NHANES — Amato et al. (2025) · supportingThe Lipedema Phenotype is Inversely Associated with Celiac Disease Autoimmunity: Testing the Immunological Shield Hypothesis in NHANES — Amato et al. (2025) · supportingThe IgG Paradox in Lipedema: More Food Sensitivities, Less Antibody Production — Amato et al. (2025) · contextLipedema in Men: A Retrospective Case Series of Five Patients From a Brazilian Referral Center — Amato et al. (2025) · supportingExploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity — Amato et al. (2026) · supporting

supporting   contradicting   refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline. The hollow ring marks the first time this topic appears in the literature.

How to cite this version

    
    

Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.

What changed in this version

This update added a very-low-quality five-patient male case series reporting HLA-DQ2/DQ8 positivity in the single typed patient and citing prior intra-lipedema HLA prevalence figures, reinforcing but not strengthening the existing emerging, low-quality signal.

Supporting claims

Contradictory claims

Refining / context

Major uncertainty

Whether any true association exists, and—if it does—its direction and clinical meaning, remain entirely unresolved: all evidence is cross-sectional or a single-patient case description with small case numbers and historical/indirect comparators, no causal mechanism has been shown, and the cited intra-lipedema HLA prevalence figures (DQ2 47.4%, DQ8 22.2%) are inconsistent across sources, so no inference about gluten-free dietary benefit can be supported.

Version history

Key references

DOI:10.7759/cureus.41594 · DOI:10.1590/S0102-67202015000300009 · DOI:10.64898/2025.12.01.25341350 · DOI:10.7759/cureus.104222 · DOI:10.7759/cureus.93788 · DOI:10.7759/cureus.87332